Bajaj HealthCare Limited

BSE:539872 Stock Report

Market Cap: ₹12.4b

Bajaj HealthCare Valuation

Is 539872 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 539872 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 539872 (₹391.45) is trading above our estimate of fair value (₹259.32)

Significantly Below Fair Value: 539872 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 539872?

Key metric: As 539872 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 539872. This is calculated by dividing 539872's market cap by their current revenue.
What is 539872's PS Ratio?
PS Ratio2.6x
Sales₹4.76b
Market Cap₹12.36b

Price to Sales Ratio vs Peers

How does 539872's PS Ratio compare to its peers?

The above table shows the PS ratio for 539872 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.5x
506414 Fermenta Biotech
2.6xn/a₹9.6b
539997 Kwality Pharmaceuticals
2.6xn/a₹9.0b
506197 Bliss GVS Pharma
1.7xn/a₹13.8b
524774 NGL Fine-Chem
3xn/a₹11.1b
539872 Bajaj HealthCare
2.6xn/a₹12.4b

Price-To-Sales vs Peers: 539872 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the peer average (2.5x).


Price to Sales Ratio vs Industry

How does 539872's PS Ratio compare vs other companies in the IN Pharmaceuticals Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
NECLIFE Nectar Lifesciences
0.4xn/aUS$89.20m
539561 Remedium Lifecare
0.07xn/aUS$28.41m
532637 Mangalam Drugs & Organics
0.5xn/aUS$20.04m
524412 Aarey Drugs & Pharmaceuticals
0.3xn/aUS$19.22m
539872 2.6xIndustry Avg. 3.1xNo. of Companies20PS02.44.87.29.612+
14 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 539872 is good value based on its Price-To-Sales Ratio (2.6x) compared to the Indian Pharmaceuticals industry average (3.1x).


Price to Sales Ratio vs Fair Ratio

What is 539872's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

539872 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 539872's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies